Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02532361 · ClinicalTrials.gov registry record
Proportion of Hysterectomy After Female Sterilization
A clinical trial, sponsored by Bayer.
- Completed
- Registry status
- 10,578
- Enrollment target
NCT02532361 is a clinical trial that has completed, run by Bayer. The registered enrollment target is 10,578 participants.
The verdict
NCT02532361 has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- 10,578 participants
- Enrollment target
Study Summary
The objective of this study is to describe the proportion of hysterectomy in patients that had undergone sterilization through hysteroscopic device placement and the patients that had undergone sterilization through tubal ligation.
Interventions
- PROCEDURE Tubal ligation
- DEVICE Hysteroscopic device placement including Essure (ESS305, BAY1454032)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,578 participants |
| Start Date | 2015-08 |
| Est. Completion | 2015-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02532361
The ClinicalTrials.gov registry entry for NCT02532361 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10,578 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tubal ligation is the first listed.
NCT02532361 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02532361 about?
NCT02532361 is a clinical study titled "Proportion of Hysterectomy After Female Sterilization". The objective of this study is to describe the proportion of hysterectomy in patients that had undergone sterilization through hysteroscopic device placement and the patients that had undergone sterilization through tubal ligation.
What is the current status of trial NCT02532361?
This trial is currently completed. The enrollment target is 10,578 participants. The study started on 2015-08. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02532361?
The interventions under investigation include: Tubal ligation (PROCEDURE), Hysteroscopic device placement including Essure (ESS305, BAY1454032) (DEVICE).
Who is sponsoring clinical trial NCT02532361?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.